Table 2

 Disease modifying antirheumatic drugs used by the patients at entry

Treatmentn (%)
Single therapy 15 (62)
Methotrexate7 (29)
Leflunomide6 (25)
Azathioprine1 (4)
Podophyllotoxine1 (4)
Combination therapy 9 (38)
Methotrexate + leflunomide1 (4)
Methotrexate + podophyllotoxine1 (4)
Methotrexate + hydroxychloroquine + podophyllotoxine2 (8)
Methotrexate + hydroxychloroquine + sulfasalazine +ciclosporine A1 (4)
Azathioprine + gold sodium thiomalate1 (4)
Azathioprine + sulfasalazine1 (4)
Podophyllotoxine + hydroxychloroquine1 (4)
Hydroxychloroquine + auranofin1 (4)